Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05899608
Title Clinical Study of Ivonescimab for First-line Treatment of Metastatic Squamous NSCLC Patients
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Summit Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN

Additional content available in CKB BOOST